ABCT Participant Directory

John Deacon

JohnDeacon-Cytosolix

Cytosolix

2018

Affiliations

Yale University

Technologies

Therapeutic

Indication

Oncology

Website

cytosolix.com

Cytosolix is developing a small-molecule tumor targeted chemotherapy platform.

Contact ABCT

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

For more information about Corporate Support and Community Service Provider Support, please contact our Senior Program Manager, Maggie El Naamani at maggie@firstxfounder.com

Program of

Initiated by